The ORAI3 expression is also elevated in breast cancer cells, where enhanced ORAI3-dependent SOCE result in apoptosis resistance, proliferation, and invasion in an estrogen receptor-dependent way (Motiani et al., 2013b). This evidence concerns the gene ORAI3 and breast carcinoma.